Ophthalmology human resource projections: Are we heading for a crisis in the next 15 years?

Canadian Journal of Ophthalmology

Volumn 42, Issue 1, 2007, Pages 34-38

  Bellan, Lorne ^a,c   Buske, Lynda ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CMAJ   (Canada)

^c Misericordia Health Centre   (Canada)

Author keywords

Health human resources; Manpower; Waiting times

Indexed keywords

ARTICLE; DEMOGRAPHY; EYE CARE; FEMALE; GRADUATE STUDENT; HEALTH SERVICE; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL SOCIETY; NORMAL HUMAN; PHYSICIAN; RESIDENCY EDUCATION;

EID: 33947160622     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1139/I06-115     Document Type: Article

References (14)

1. Newton S, Buske L. Physician resource evaluation template: a model for estimating future supply in Canada. Annals RCPSC 1998;31:145-50.
2. CIHI. Full-time Equivalent Physicians (FTE) Report, Canada. 2006. Available: http://secure.cihi.ca/cihiweb/dispPage.jsp?cw_page= AR_17_E&cw_topic=17 (accessed 2006 Aug 10).
3. StatsCan. Population and growth rate, selected age segments, Canada, 1991, 2001 and 2011. 2006. Available: http://www12.statcan.ca/english/census01/ Products/Analytic/companion/age/popgaint.cfm (accessed 2006 Aug 10).
4. Valberg JD. Manpower Study Four implies future supply and demand for ophthalmologists is balanced. Can J Ophthalmol 1989;24:286-91.
5. Anderson DP. Challenges for the future of eye care in Canada. Can J Ophthalmol 2003;38:261, 263.
6. Mitchell P. Ophthalmology in Australia. Arch Ophthalmol 2002;120:1375-6.
7. A.W. Pratt. The pig and the python come to ophthalmology. Perspectives - The Newsletter of the Canadian Ophthalmological Society. 2000.
8. Roos NP, Fransoo R. How many surgeons does a province need, and how do we determine appropriate numbers? Healthc Manage Forum 2001;14:11-21.
9. Persaud DD, Cockerill R, Pink G, Trope G. Determining Ontario's supply and requirements for ophthalmologists in 2000 and 2005: 2. A comparison of projected supply and requirements. Can J Ophthalmol 1999;34:82-7.
10. Roos NP, Bradley JE, Fransoo R, Shanahan M. How many physicians does Canada need to care for our aging population? CMAJ 1998;158:1275-84.
11. Wait Times Alliance. It's About Time! Ottawa, Ont: Canadian Medical Association; 2005.
12. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006;113:363-72.
13. D'Amico DJ, Patel M, Adamis AP, Cunningham ET, Jr., Guyer DR, Katz B. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 2006;113:1001-6.
14. Rosenfeld PJ, Heier JS, Hantsbarger G, Shams N. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration. Ophthalmology 2006;113:632.